
doi: 10.1002/msc.123
pmid: 18050263
Tumor Necrosis Factor-alpha, Antibodies, Monoclonal, Professional Practice, Infliximab, Receptors, Tumor Necrosis Factor, Etanercept, Arthritis, Rheumatoid, Treatment Outcome, Rheumatology, Antirheumatic Agents, Immunoglobulin G, Humans, Practice Patterns, Physicians', Algorithms
Tumor Necrosis Factor-alpha, Antibodies, Monoclonal, Professional Practice, Infliximab, Receptors, Tumor Necrosis Factor, Etanercept, Arthritis, Rheumatoid, Treatment Outcome, Rheumatology, Antirheumatic Agents, Immunoglobulin G, Humans, Practice Patterns, Physicians', Algorithms
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
